Sign in

CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company

TriSalus Life Sciences, Inc.

Sign in to watch
Ticker
TLSI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853009869
Phone
415 336 8917
Business address
6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
Former names
MedTech Acquisition Corp, MedTech Acquisition Corporation

Securities

  • TLSI Common Stock Nasdaq
  • TLSIW Warrant Nasdaq
  1. 4 Grant or award Chief Regulatory Officer acquired 50,000 shares (grant or award)
  2. 4 Grant or award Chief Commercial Officer acquired 60,000 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Chief Financial Officer acquired 13,175 shares (grant or award)
  15. 4 Open-market sale Chief of Research sold 4,764 shares at $5.18 ($24,678)
  16. 4 Open-market sale Chief of Clinical Operations sold 4,764 shares at $5.18 ($24,678)
  17. 4 Open-market sale Chief Commercial Officer sold 6,597 shares at $5.18 ($34,172)
  18. 4 Grant or award Director acquired 44,884 shares (grant or award)
  19. 4 Open-market sale Chief Regulatory Officer sold 8,704 shares at $5.18 ($45,087)
  20. 4 Grant or award Chief Manuf, Strategy&Bus Dev. acquired 15,817 shares (grant or award)

Page 3 of 9 · 163 filings